267 related articles for article (PubMed ID: 18363759)
1. Histopathologically dysplastic neurofibromas in neurofibromatosis 1: diagnostic criteria, prevalence and clinical significance.
Valeyrie-Allanore L; Ortonne N; Lantieri L; Ferkal S; Wechsler J; Bagot M; Wolkenstein P
Br J Dermatol; 2008 May; 158(5):1008-12. PubMed ID: 18363759
[TBL] [Abstract][Full Text] [Related]
2. Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1.
Valeyrie-Allanore L; Ismaïli N; Bastuji-Garin S; Zeller J; Wechsler J; Revuz J; Wolkenstein P
Br J Dermatol; 2005 Jul; 153(1):79-82. PubMed ID: 16029330
[TBL] [Abstract][Full Text] [Related]
3. Association between benign and malignant peripheral nerve sheath tumors in NF1.
Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM
Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787
[TBL] [Abstract][Full Text] [Related]
4. Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysis.
Koga T; Iwasaki H; Ishiguro M; Matsuzaki A; Kikuchi M
J Pathol; 2002 May; 197(1):98-107. PubMed ID: 12081210
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis 1 phenotype associated to malignant peripheral nerve sheath tumours: a case-control study.
Zehou O; Bularca S; Bastuji-Garin S; Ortonne N; Valeyrie-Allanore L; Wolkenstein P; Duong TA
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1044-7. PubMed ID: 22348274
[TBL] [Abstract][Full Text] [Related]
6. Plexiform neurofibroma with and without associated malignant peripheral nerve sheath tumor: a clinicopathologic and immunohistochemical analysis of 54 cases.
McCarron KF; Goldblum JR
Mod Pathol; 1998 Jul; 11(7):612-7. PubMed ID: 9688181
[TBL] [Abstract][Full Text] [Related]
7. Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis.
Lévy P; Bièche I; Leroy K; Parfait B; Wechsler J; Laurendeau I; Wolkenstein P; Vidaud M; Vidaud D
Clin Cancer Res; 2004 Jun; 10(11):3763-71. PubMed ID: 15173083
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.
Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I
Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis 1-associated neuropathies: a reappraisal.
Drouet A; Wolkenstein P; Lefaucheur JP; Pinson S; Combemale P; Gherardi RK; Brugières P; Salama J; Ehre P; Decq P; Créange A
Brain; 2004 Sep; 127(Pt 9):1993-2009. PubMed ID: 15289270
[TBL] [Abstract][Full Text] [Related]
10. SOX9 expression increases with malignant potential in tumors from patients with neurofibromatosis 1 and is not correlated to desert hedgehog.
Carbonnelle-Puscian A; Vidal V; Laurendeau I; Valeyrie-Allanore L; Vidaud D; Bièche I; Leroy K; Lantieri L; Wolkenstein P; Schedl A; Ortonne N
Hum Pathol; 2011 Mar; 42(3):434-43. PubMed ID: 21193222
[TBL] [Abstract][Full Text] [Related]
11. Is a plexiform neurofibroma pathognomonic of neurofibromatosis type I?
Lin V; Daniel S; Forte V
Laryngoscope; 2004 Aug; 114(8):1410-4. PubMed ID: 15280718
[TBL] [Abstract][Full Text] [Related]
12. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1.
Waggoner DJ; Towbin J; Gottesman G; Gutmann DH
Am J Med Genet; 2000 May; 92(2):132-5. PubMed ID: 10797438
[TBL] [Abstract][Full Text] [Related]
13. [Extracerebral neoplastic manifestations in neurofibromatosis 1: integrated diagnostic imaging].
Ferrozzi F; Zuccoli G; Bacchini E; Piazza P; Sigorini M; Virdis R
Radiol Med; 1998 Dec; 96(6):562-9. PubMed ID: 10189917
[TBL] [Abstract][Full Text] [Related]
14. [Pathologic characteristics of the most frequent peripheral nerve tumors].
Coulon A; Milin S; Laban E; Debiais C; Jamet C; Goujon JM
Neurochirurgie; 2009 Oct; 55(4-5):454-8. PubMed ID: 19744677
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.
Ferner RE; Lucas JD; O'Doherty MJ; Hughes RA; Smith MA; Cronin BF; Bingham J
J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):353-7. PubMed ID: 10675220
[TBL] [Abstract][Full Text] [Related]
16. Benign nerve sheath tumors on urinary bladder biopsy.
Wang W; Montgomery E; Epstein JI
Am J Surg Pathol; 2008 Jun; 32(6):907-12. PubMed ID: 18425043
[TBL] [Abstract][Full Text] [Related]
17. Neurofibroma and schwannoma.
Ferner RE; O'Doherty MJ
Curr Opin Neurol; 2002 Dec; 15(6):679-84. PubMed ID: 12447105
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous malignant peripheral nerve sheath tumors.
Thomas C; Somani N; Owen LG; Malone JC; Billings SD
J Cutan Pathol; 2009 Aug; 36(8):896-900. PubMed ID: 19586501
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 proliferation-index (MIB-1) of neurofibromas in neurofibromatosis type 1 patients.
Friedrich RE; Hagel C; Brehme Z; Kluwe L; Mautner VF
Anticancer Res; 2003; 23(2A):953-5. PubMed ID: 12820329
[TBL] [Abstract][Full Text] [Related]
20. MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas.
Wasa J; Nishida Y; Tsukushi S; Shido Y; Sugiura H; Nakashima H; Ishiguro N
AJR Am J Roentgenol; 2010 Jun; 194(6):1568-74. PubMed ID: 20489098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
